nonacog alfa · Medicine question

What is the mean elimination half-life of BeneFIX (nonacog alfa) in adults aged 18–60 years in the population pharmacokinetic analysis?

Name: What is the mean elimination half-life of BeneFIX (nonacog alfa) in adults aged 18–60 years in the population pharmacokinetic analysis?
Published: 2026-11-08T14:22:34.486Z

iatroX medicinesPublished 8 November 2026

The answer

Answer

BeneFIX (nonacog alfa) had a mean elimination half-life of 23.9 hours (SD 4.5 hours) in 30 adults aged 18–60 years in the population pharmacokinetic analysis.

Sources for this answer

BeneFIX 250 IU powder and solvent for solution and injectionPfizer Limited · emc · SmPC §5.2 Pharmacokinetic properties · Version 27Document updated 19 October 2021

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about nonacog alfa